CVI Webinar 2021: Modifying Peripheral Artery Compliance During Endovascular Intervention: Lessons Learned
January 14, 2021 – January 14, 2022
This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.
The goal of this activity is to provide participants with knowledge and state-of-the-art management information on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.
- Describe current tools for crossing complex tibial occlusions
- Outline the role of DES in tibial disease
- Describe when atherectomy is indicated for tibial disease
- List alternative therapies for tibial disease treatment
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date: January 14, 2021 End Date: January 14, 2022
There is no registration fee for this activity.
- View webinar
- At the end of the webinar, login to: https://online-med-edu.com/cvi2021/webinar/artery (you are here)
- Complete the Evaluation/Credit Request Form-No credit requests will be accepted after January 14, 2022
- Download or Print Credit Statement
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Sudhash Banerjee, MD
Chief of Cardiology, VA North Texas Health Care System
Sudhash Banerjee has disclosed the following relevant financial relationships: AstraZeneca-Speaker Bureau; Boston Scientific-Institutional Research Grant; Livmore, Inc.-Consultant
Matthew Bunte, MD
Director of Vascular Medicine, Saint Luke's Mid America Heart Institute
Lee’s Summit, MO
Matthew Bunte has no relevant financial relationships to disclose.
Venita Chandra, MD
Vascular Surgeon, Stanford University
Venita Chandra has no relevant financial relationships to disclose.
Lawrence A. Garcia, MD
Chief, Section Interventional Cardiology and Vascular Interventions, Steward St. Elizabeth’s Medical Center
Lawrence Garcia has disclosed the following relevant financial relationships: Abbott, BSC, Covidien/Medtronic- Consultant, Research Grant; Philips, Syntervention, Arsenal-Consultant
Sahil A. Parikh, MD
Associate Professor of Medicine, NY Presbyterian/Columbia University Medical Center
New York, NY
Sahil Parikh has no relevant financial relationship to disclose
Mehdi Shishehbor, DO, MPH, PhD
Director, Cardiovascular Interventional Center, University Hospitals Cleveland Medical Center
Mehdi Shishehbor has no relevant financial relationship to disclose
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support for this educational activity will be provided by the following:
- Boston Scientific